
Abiomed ABMD
Quarterly report 2022-Q3
added 11-03-2022
Abiomed Cash Conversion Cycle 2011-2026 | ABMD
Annual Cash Conversion Cycle Abiomed
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 156 | 175 | 180 | 142 | 118 | 173 | 109 | 109 | 137 | 122 | 75.8 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 180 | 75.8 | 136 |
Quarterly Cash Conversion Cycle Abiomed
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 78.9 | 34 | - | 143 | 149 | 68.2 | 140 | 168 | 169 | 176 | 200 | 175 | 170 | 179 | 155 | 154 | 129 | 121 | 113 | 125 | 140 | 117 | 113 | 122 | 136 | 153 | 35.3 | 39.3 | 38 | 39.5 | 37.4 | 37.9 | 33.7 | 41.4 | 44.2 | 43.5 | 41.6 | 45.2 | 45.8 | 46.2 | 44.3 | 47.3 | 44.4 | 46.5 | 42.5 | 46.3 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 200 | 33.7 | 94.9 |
Cash Conversion Cycle of other stocks in the Medical devices industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
137 | $ 178.43 | 6.92 % | $ 13.4 B | ||
|
AxoGen
AXGN
|
245 | $ 33.07 | 6.7 % | $ 1.52 B | ||
|
Conformis
CFMS
|
165 | - | - | $ 16.4 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
104 | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
761 | - | -26.83 % | $ 2.62 M | ||
|
ClearPoint Neuro
CLPT
|
217 | $ 9.23 | 1.71 % | $ 261 M | ||
|
AdaptHealth Corp.
AHCO
|
20.1 | $ 12.22 | 2.3 % | $ 1.65 B | ||
|
Cardiovascular Systems
CSII
|
172 | - | 0.15 % | $ 844 M | ||
|
Allied Healthcare Products
AHPI
|
271 | - | 3.58 % | $ 2.21 M | ||
|
Lianluo Smart Limited
LLIT
|
94.1 | - | 24.59 % | $ 44.8 M | ||
|
Dynatronics Corporation
DYNT
|
80.5 | - | 14.99 % | $ 929 K | ||
|
Obalon Therapeutics, Inc.
OBLN
|
174 | - | -5.86 % | $ 30.6 M | ||
|
Bruker Corporation
BRKR
|
227 | $ 38.3 | 4.45 % | $ 5.71 K | ||
|
Second Sight Medical Products
EYES
|
-29.6 | - | -0.97 % | $ 54.4 M | ||
|
GBS
GBS
|
204 | - | -0.57 % | $ 7.12 M | ||
|
Helius Medical Technologies
HSDT
|
18.2 | $ 1.88 | 2.73 % | $ 1.14 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
222 | $ 9.61 | 2.95 % | $ 740 M | ||
|
Apollo Endosurgery
APEN
|
156 | - | - | $ 475 M | ||
|
Inogen
INGN
|
48.9 | $ 6.73 | -1.03 % | $ 179 M | ||
|
IRIDEX Corporation
IRIX
|
105 | $ 1.14 | 10.68 % | $ 19.3 M | ||
|
Integer Holdings Corporation
ITGR
|
96.8 | $ 87.26 | 2.53 % | $ 3.03 B | ||
|
Electromed
ELMD
|
180 | $ 24.45 | 2.82 % | $ 207 M | ||
|
OrthoPediatrics Corp.
KIDS
|
714 | $ 15.95 | 1.21 % | $ 374 M | ||
|
Globus Medical
GMED
|
314 | $ 91.99 | 2.21 % | $ 12.4 B | ||
|
LENSAR
LNSR
|
85.4 | $ 5.6 | -0.53 % | $ 67 M | ||
|
EDAP TMS S.A.
EDAP
|
136 | $ 3.36 | -1.29 % | $ 126 M | ||
|
Medtronic PLC
MDT
|
160 | $ 88.34 | 2.22 % | $ 114 B | ||
|
CryoLife, Inc.
CRY
|
183 | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
335 | - | -20.74 % | $ 369 K | ||
|
Invacare Corporation
IVC
|
214 | - | - | $ 24.7 M | ||
|
Myomo
MYO
|
82.3 | $ 0.68 | 0.03 % | $ 28.5 M | ||
|
Axonics Modulation Technologies
AXNX
|
299 | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-81.2 | - | 1.37 % | $ 20.5 M | ||
|
Soliton, Inc.
SOLY
|
-67.9 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-227 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
81.2 | - | - | $ 111 M | ||
|
Sintx Technologies
SINT
|
279 | $ 2.73 | 2.62 % | $ 7.57 M | ||
|
Butterfly Network
BFLY
|
815 | $ 4.15 | 2.47 % | $ 878 M | ||
|
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | ||
|
Nevro Corp.
NVRO
|
297 | - | - | $ 217 M | ||
|
Stryker Corporation
SYK
|
337 | $ 338.41 | 1.91 % | $ 129 B | ||
|
Cytosorbents Corporation
CTSO
|
104 | $ 0.62 | 1.66 % | $ 38.6 M | ||
|
Tactile Systems Technology
TCMD
|
99.9 | $ 24.36 | 1.29 % | $ 557 M | ||
|
TransMedics Group
TMDX
|
111 | $ 108.31 | 0.92 % | $ 3.68 B | ||
|
Tandem Diabetes Care
TNDM
|
249 | $ 19.47 | 6.51 % | $ 1.32 B | ||
|
BIOLASE
BIOL
|
129 | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
258 | $ 9.86 | 1.96 % | $ 353 M |